Vascular Surgery OS
Start learning
← All domains
Procedure guide

Transfemoral (above-knee) amputation

A practical guide to above-knee amputation: selection, operative technique, muscle balance, complications and rehabilitation.

Written September 2, 2026 · Mr Razhan K Ali

Purpose & indications

Above-knee amputation (AKA) removes an unsalvageable or non-functional limb through the femur. The aim is a healed, comfortable residual limb that supports transfers and, where feasible, prosthetic walking. [1–3]

Indications include irreversible ischaemia, uncontrolled infection or tissue destruction, failed reconstruction without a useful salvage option, and a painful non-functional limb. These justify considering amputation—not automatically an above-knee level. [1,7]

For chronic limb-threatening ischaemia (CLTI), consider all revascularisation options through the vascular MDT before major amputation, including inflow treatment that could permit a lower level. Do not delay urgent source control for life-threatening sepsis. [6–8]

Consent

Discuss pain relief, source control and achievable function; alternatives include further limb salvage, a lower amputation level and non-operative or palliative care. Explain bleeding/transfusion, wound failure or infection, revision or higher amputation, neuroma, residual-limb and phantom pain, venous thromboembolism, major cardiopulmonary complications and death. Set realistic expectations for walking, wheelchair use and transfers; neither prosthetic use nor freedom from pain is guaranteed. [1–3,8]

Anatomy & planning

Quadriceps lie anteriorly, adductors medially and hamstrings posteriorly. The femoral vessels run beneath sartorius in the adductor canal, between vastus medialis and the adductors. Profunda perforators cross adductor magnus into the posterior compartment; the sciatic nerve lies separately in the posterior thigh. Loss of the distal adductor magnus attachment leaves the femur prone to abduction. [1,2,4]

Assess perfusion, infection extent, tissue viability, previous bypasses, hip movement and baseline function. Check imaging for femoral metalwork. Perfusion tests support level selection but cannot guarantee healing. Arrange rehabilitation and prosthetic assessment before non-emergency surgery where feasible, agreeing goals with the patient. [1,2,5,7,8]

Operative strategy

Choose the lowest level likely to heal and provide useful function; consider below-knee or through-knee options rather than defaulting to AKA because the patient uses a wheelchair. [1,2,7]

For conventional prosthetic fitting, plan femoral division about 12 cm above the medial knee joint line (10–15 cm acceptable), adjusted to tissue coverage and prosthetic requirements. This is the bone level, not the skin-incision level. [2]

Plan flap coverage, bone length and muscle fixation together. Equal anterior/posterior fish-mouth flaps are common; viable tissue dictates their shape. Preserve adductor magnus and quadriceps tendon for planned myodesis. Gross infection or uncertain viability may require an open/staged operation rather than definitive closure. [1–3]

Setup

Confirm side, level and consent. Position supine with the hip free to move; isolate the diseased distal limb and protect the opposite heel. Prepare vascular clamps/ligatures, bone guard, saw, rasp and, for myodesis, a drill and fixation sutures. [1–3,5]

Agree anaesthesia, blood availability, postoperative care and antithrombotic management. Give peri-incision antibiotics; established infection requires a separate treatment plan. Tourniquet use is selective. [3,8]

Plan opioid-sparing multimodal analgesia with the anaesthetic/pain team. When continuous perineural analgesia is used for AKA, cover both femoral and sciatic territories. Catheter placement, monitoring and removal follow the agreed pathway; these are consensus-informed choices, not proof of one superior regimen. [11]

Perform

Phase A — Create flaps and preserve muscle

Mark the bone level and flaps. An adjustable marking aid is an anterior and posterior flap each approximately one-quarter of the thigh circumference at the intended bone level. Incise skin, subcutaneous tissue and fascia without bevelling or undermining; ligate the great saphenous vein and control superficial bleeding. [1–3,5]

Retain sufficient distal adductor magnus and quadriceps musculotendinous length for planned fixation. If infection or non-viable tissue reaches the proposed residual limb, reassess the level or staging before proceeding. [1,2]

Phase B — Control vessels

Divide muscle progressively. Identify the superficial femoral artery and femoral vein in the adductor canal; dissect and secure each separately with suture ligatures before division. Control profunda perforators and muscular vessels as encountered. Identify the sciatic nerve before completing posterior soft-tissue division. [1–4]

Identify any previous bypass before division. Consider removal of retained synthetic material to reduce stump infection, while planning the extent around graft involvement, inflow and operative risk. [1,13] For graft infection, explantation and debridement are first-line, with revascularisation when indicated; partial removal or preservation is reserved for selected limited infections. Document the plan for any retained proximal graft. [13]

Phase C — Divide and prepare the femur

Expose only enough femur for the cut; excessive periosteal stripping risks devascularisation. Protect the soft tissues with a bone guard, divide at the planned level, smooth sharp edges and irrigate away bone debris. Confirm that viable muscle and skin can cover the bone without tension. [1,3,5]

Phase D — Manage nerves

Transect the sciatic and other major nerves sharply under gentle tension. Check nerve-end haemostasis before allowing retraction into healthy proximal tissue away from the distal scar; a ligature may be used on a large nerve with accompanying vessels. Avoid crushing or forceful traction. [1–3]

Complete the remaining soft-tissue division and remove the limb once vessels and nerves are controlled. Complete the agreed perineural catheter plan. Conventional nerve handling does not guarantee prevention of neuroma or phantom pain; comparative evidence remains limited. [2,11]

Phase E — Balance muscle

Myodesis fixes muscle/tendon to bone; myoplasty joins opposing muscle groups. Choose fixation according to muscle quality and functional goals. [1,2]

For adductor myodesis, bring adductor magnus over the femoral end and secure it through lateral cortical drill holes with the femur adducted. Cover the bone with quadriceps, securing it posteriorly with the hip neutral or extended, and complete balanced muscle coverage. Described fixation positions vary; avoid over-tension, excessive bulk and an abducted residual femur. Formal myodesis is not established as mandatory for every dysvascular amputee. [1,2]

Phase F — Close without tension

Release any tourniquet and check vessels, muscle and bone for bleeding. Gently flex the hip before closure: if muscle or skin becomes tight, revise coverage or shorten the femur rather than forcing the edges together. Close the musculofascial layers and skin without strangulation; do not sacrifice viable flap corners merely for cosmesis. [1–3]

ERAS/SVS advises against routine drains, although some operative descriptions use them routinely; the supporting evidence is low certainty. Selective drainage never replaces haemostasis. Apply a protective, non-constricting dressing. [1,3,5,12]

Technical pearls & pitfalls

Skin and bone markings are different; do not substitute the patella for the medial joint-line landmark. Preserve reconstructive muscle before dividing it, but never retain infected or poorly perfused tissue merely to gain length. [1,2,5]

Completion

Confirm viable coverage, secure haemostasis, protected nerve ends and tension-free closure—or a documented staged wound plan. Record bone level, graft handling, muscle/nerve management, drains/catheters and any return to theatre. Specify antibiotics, thromboprophylaxis, analgesia, wound review and rehabilitation; complete the National Vascular Registry record. [1–3,5,8]

Complications & rescue

ProblemRecognition and response
Bleeding/haematoma Increasing swelling, pain, blood loss or physiological deterioration require assessment and resuscitation. Evacuate a significant or expanding haematoma and secure haemostasis; do not simply tighten the dressing. [1,3]
Flap ischaemia/wound failure Pallor, coolness, persistent pain, blistering or necrosis: remove external constriction and reassess inflow, viability and closure tension. Debridement or revision to a higher level may be necessary. [1,3]
Deep infection Purulent drainage, wound breakdown or systemic illness require antibiotics and source control. Drain collections, debride non-viable tissue and reassess retained graft material. [1–3,13]
Hip contracture Prevent prolonged flexion/abduction with balanced reconstruction, positioning and early physiotherapy. Loss of extension or persistent abduction warrants early rehabilitation review before contracture compromises transfers or prosthetic fitting. [1,2]

Distinguish residual-limb pain from pain perceived in the absent limb. Exclude bleeding, ischaemia, infection and mechanical causes before attributing new pain to phantom pain; persistent focal neuroma-type pain requires specialist assessment. [1,2]

Postoperative management

Surveillance and pain. Monitor haemodynamics, renal function, glucose, wound and cardiopulmonary status; check haemoglobin when indicated. Review analgesia and catheters, avoiding excessive sedation. Suspected bleeding, ischaemia or infection requires immediate wound assessment rather than waiting for a scheduled dressing change. [1,2,8,11]

Antibiotics—evidence conflict. ERAS/SVS suggests prophylaxis for no more than 24 hours, whereas a single-centre UK RCT found fewer surgical-site infections with five days; benefit persisted when minor amputations were excluded. The trial excluded significant infection requiring immediate or prolonged treatment. Follow the local amputation/microbiology protocol and record a stop/review date; prophylaxis findings do not determine treatment duration for residual infection. [10,12]

Thromboprophylaxis. NICE advises considering LMWH for at least seven days when VTE risk exceeds bleeding risk. If pharmacological prophylaxis is contraindicated, consider contralateral intermittent pneumatic compression on admission after assessing limb suitability; continue until mobility is no longer significantly reduced relative to anticipated mobility. Do not use anti-embolism stockings in suspected or proven PAD.[9]

Rehabilitation. Begin physiotherapy, occupational therapy, safe transfers and wheelchair planning early. Maintain hip extension and avoid prolonged flexed positioning; supervised prone positioning may help when tolerated. Protect the remaining foot/heel and address nutrition, psychological support and home needs. Prosthetic assessment starts before surgery where feasible; fitting and loading depend on healing and functional readiness. [1–3,8,12]

Continue PAD secondary prevention. After CLTI-related amputation, review at least annually to monitor the contralateral limb and maintain medical therapy and risk-factor management. [7]

Remember

A useful residual limb needs adequate perfusion, viable padding, muscle balance and tension-free closure. Rehabilitation begins with the decision to amputate—not after wound healing. [1,2,7]

References

  1. Sidawy AN, Perler BA, editors. Rutherford’s Vascular Surgery and Endovascular Therapy. 10th ed. Elsevier; 2023. Chapters 114–115.
  2. Loftus I, Hinchliffe RJ, editors. Vascular and Endovascular Surgery: A Companion to Specialist Surgical Practice. 7th ed. Elsevier; 2024. Chapter 6.
  3. Chaikof EL, Cambria RP, editors. Atlas of Vascular Surgery and Endovascular Therapy: Anatomy and Technique. Saunders; 2014. Chapter 51.
  4. Wind GG, Valentine RJ. Anatomic Exposures in Vascular Surgery. 3rd ed. Lippincott Williams & Wilkins; 2013. Chapter 16.
  5. Forsyth JM. How to Be a Safe Consultant Vascular Surgeon from Day One: The Unofficial Guide to Passing the FRCS (VASC). CRC Press; 2023. Chapter 35. doi:10.1201/b22951-35.
  6. National Institute for Health and Care Excellence. Peripheral arterial disease: diagnosis and management. CG147. Recommendations. Accessed 2 October 2026.
  7. Conte MS, Bradbury AW, Kolh P, et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg. 2019;69(6 Suppl):3S–125S.e40. doi:10.1016/j.jvs.2019.02.016.
  8. Vascular Society of Great Britain and Ireland. A Best Practice Clinical Care Pathway for Major Amputation Surgery. April 2016. Pathway.
  9. National Institute for Health and Care Excellence. Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism. NG89. Recommendations. Accessed 2 October 2026.
  10. Souroullas P, Barnes R, Carradice D, Smith G, Huang C, Chetter I. Extended-course antibiotic prophylaxis in lower limb amputation: randomized clinical trial. Br J Surg. 2022;109(5):426–432. doi:10.1093/bjs/znac053.
  11. Ekkunagul T, MacLeod CS, Celnik A, et al. Peri-operative pain management in major lower extremity amputation in vascular surgery: a UK anaesthetic and vascular surgery Delphi consensus study. Anaesthesia. 2026;81(5):664–674. doi:10.1111/anae.70107.
  12. McGinigle KL, O’Banion LA, Settembrini AM, et al. A framework for perioperative care in lower extremity major limb amputation: a consensus statement by the Enhanced Recovery After Surgery (ERAS) Society and Society for Vascular Surgery. JVS–Vascular Insights. 2024;2:100156. doi:10.1016/j.jvsvi.2024.100156.
  13. Lejay A, Saleem BR, Barwick TD, et al. Editor’s Choice—European Society for Vascular Surgery (ESVS) 2026 Clinical Practice Guidelines on the Management of Vascular Graft and Endograft Infections. Eur J Vasc Endovasc Surg. 2026;72:227–293. doi:10.1016/j.ejvs.2026.05.035.